Periodontitis Therapeutic Pipeline and Development Review H1 2015 Research Report

DALLAS, March 24, 2015 /PRNewswire/ --

RnRMarketResearch.com adds "Periodontitis - Pipeline Review, H1 2015" therapeutic market research report of 47 pages with latest updates, data and information to its online business intelligence library.

The report "Periodontitis - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Periodontitis. Periodontitis is a serious gum infection that damages the soft tissue and destroys the bone that supports teeth. Periodontitis can cause tooth loss or worse, an increased risk of heart attack or stroke and other serious health problems. Periodontitis is usually the result of poor oral hygiene. Signs and symptoms of periodontitis can include swollen gums, Bright red or purplish gums, Gums that feel tender when touched, Gums that pull away from teeth (recede), teeth look longer than normal, new spaces developing between teeth, Pus between teeth and gums, Bad breath, Bad taste in mouth, loose teeth.

This report is complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Periodontitis and special features on late-stage and discontinued projects.

Companies discussed in this report include:

• CSL Limited
• Ensoltek Co., Ltd.
• Geistlich Pharma AG
• Kaken Pharmaceutical Co., Ltd.
• NeoStem, Inc.

Drug Profiles discussed in this report include AMY-101, Drug to Antagonize C5aR for Periodontitis, Drugs for Periodontitis, GM-0111, Hesed-3000, POD CRC-OHS, Small Molecules to Inhibit Lysine Decarboxylase for Periodontal Disease, Stem Cell Therapy for Osteoporosis and Periodontitis, taurolidine, trafermin. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=314355 . (This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases cover by this report includes: May 20, 2014: Penn Team Identifies Promising New Target for Gum Disease Treatment; Nov 20, 2012: NeoStem Receives Notification Of $1.2m NIH Grant Award For First Clinical Study Of VSEL Technology In Humans; Mar 30, 2012: Kaken Pharma To Initiate Additional Phase III Trial For KCB-1D; Oct 21, 2004: Kaken Pharmaceutical Announces Results Of Early Phase II Clinical Trial On KCB-1D.

The scope of the report ranges from global therapeutic landscape of Periodontitis to the recent news and deals undertaken in the field of pipeline review. There is a detailed assessment of monotherapy and combination therapy pipeline projects along with a products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The person referring to the report will be able to devise his R&D development strategies as it includes significant competitor information, analysis and valuable insights. The report mentions the new entrants to the market and the emerging players. The report also helps in developing and designing in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Explore more reports on Oral Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/oral-therapeutics .

More reports on Oral Therapeutics:

Hand, Foot And Mouth Disease - Pipeline Review, H1 2015 

This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hand, Foot And Mouth Disease and special features on late-stage and discontinued projects. Companies discussed in this report include Chongqing Zhifei Biological Products Co., Ltd., CJ CheilJedang Corp., iQur Ltd., Sentinext Therapeutics Sdn Bhd, Sinovac Biotech Ltd., Takeda Pharmaceutical Company Limited. Complete report available at http://www.rnrmarketresearch.com/hand-foot-and-mouth-disease-pipeline-review-h1-2015-market-report.html .

Oropharyngeal Candidiasis - Pipeline Review, H1 2015 

This report provides comprehensive information on the therapeutic development for Oropharyngeal Candidiasis. The report reviews key pipeline products under drug profile section which includes product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. Companies discussed in this report include Eisai Co., Ltd., Onxeo SA. Complete report available at http://www.rnrmarketresearch.com/oropharyngeal-candidiasis-pipeline-review-h1-2015-market-report.html .

Xerostomia - Pipeline Review, H1 2015 

This report provides comprehensive information on the therapeutic development for Xerostomia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Companies discussed in this report include Acacia Pharma Ltd., Hadasit Medical Research Services & Development Ltd, Kadmon Corporation, LLC, Parion Sciences, Inc. Complete report available at http://www.rnrmarketresearch.com/xerostomia-pipeline-review-h1-2015-market-report.html .

About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari    
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com